| abstract |
Disclosed is a dosage regimen for trans-clomiphene. The present invention relates to the use of a composition comprising trans-clomiphene for treating males with hypogonadism. The present invention also includes hypogonadism and related disorders (decreased muscle mass, limited body performance capacity, decreased bone density, decreased libido, decreased sexual capacity, reduced benign prostatic hyperplasia and infertility. The present invention relates to a method for treating males having The present invention comprises 0% (w / w) to 29% (w / w) cis-clomiphene and 100% w / w to 71% w / w trans-clomiphene or a pharmaceutically acceptable salt thereof. It relates to a method of administering a composition comprising it. The composition may consist essentially of trans-clomiphene or an analog thereof. [Selection] Figure 1 |